Mesenchymal stem cells and rheumatoid arthritis

Joint Bone Spine

Volumn 70, Issue 6, 2003, Pages 483-485

  Jorgensen, Christian ^a,b   Djouad, Farida ^b   Fritz, Vanessa ^b   Apparailly, Florence ^b   Plence, Pascale ^b   Noël, Danielle ^b  

^a LAPEYRONIE HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Immunotherapy; Rheumatoid arthritis; Stem cells

Indexed keywords

AUTOIMMUNE DISEASE; CELL MIGRATION; CONFERENCE PAPER; IMMUNOREACTIVITY; IMMUNOTHERAPY; MESENCHYMAL STEM CELL; MESENCHYME CELL; RHEUMATOID ARTHRITIS; SYNOVIUM;

EID: 0347363675     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2003.08.001     Document Type: Conference Paper

References (20)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7.
2. Illei GG, Lipsky PE. Novel, non-antigen-specific therapeutic approaches to autoimmune/inflammatory diseases. Curr Opin Immunol 2000;12:712-8.
3. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276:71-4.
4. Gronthos S, Simmons PJ. The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood 1995;85:929-40.
5. Deans RJ. Mesenchymal stem cells: cell and gene therapy applications. Eur Cytokine Netw 2000;11:323-4.
6. Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000;28:875-84.
7. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99:3838-43.
8. Saito T, Kuang JQ, Bittira B, Al-Khaldi A, Chiu RC. Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann Thorac Surg 2002;74:19-24 [Discussion 24].
9. Devine SM, Mierisch CM, Jang E, Anderson PC, Balian G. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 2001;29:244-55.
10. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999;5:309-13.
11. Marinova-Mutafchieva L, Taylor P, Funa K, Maini RN, Zvaifler NJ. Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint. Arthritis Rheum 2000;43:2046-55.
12. Marinova-Mutafchieva L, Willimas RO, Funa K, Maini RN, Zwaifler NJ. Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis. Arthritis Rheum 2002;46:507-13.
13. Sen M, Lauterbach K, El-Gabalawy H, Firestein G, Corr M, Carson DA. Expression and function of wingless and frizzled homologs in rheumatoid arthritis. PNAS 2000;10:1073-86.
14. Hardiman G, Albright S, Tsunoda J, Mcclanahan T, Lee F. The mouse Wnt10b gene isolated from helper T cells is widely expressed and a possible oncogene in BR6 mouse mammary tumorigenesis. Gene 1996;172:199-205.
15. Harrington K, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, et al. Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery? Hum Gene Ther 2002;13:1263-80.
16. Gazit D, Turgeman G, Kelley P. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapy. J Gene Med 1999;1:121-33.
17. Allay JA, Dennis JE, Haynesworth SE, Majumdar MK, Clapp DW, Shultz LD, et al. LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors. Hum Gene Ther 1997;8:1417-27.
18. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, et al. Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo. Hum Gene Ther 2001;12:1527-41.
19. Liu L, Fujiki K, Dixon B, Expression of soluble TNF-RII from transduced human mesenchymal stem cells: in vitro and in vivo efficacy (abstract). Blood 1999;94.
20. Ishida T, Inaba M, Hisha H, Sugiura K, Adachi Y, Nagata N, et al. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor. J Immunol 1994;152:3119-27.